• Featured Product
  • KD/KO Validated

STK39 Rekombinanter Antikörper

STK39 Rekombinant Antikörper für WB, IF/ICC, IF-P, Sandwich ELISA, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IF/ICC, IF-P, Sandwich ELISA, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

230382G9

Kat-Nr. : 83081-2-PBS

Synonyme

230382G9, DCHT, PASK, SPAK, Ste 20 related kinase



Geprüfte Anwendungen

Produktinformation

83081-2-PBS bindet in WB, IF/ICC, IF-P, Sandwich ELISA, Indirect ELISA STK39 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen STK39 fusion protein Ag34503
Vollständiger Name serine threonine kinase 39 (STE20/SPS1 homolog, yeast)
Berechnetes Molekulargewicht59 kDa
Beobachtetes Molekulargewicht65 kDa
GenBank-ZugangsnummerBC166614
Gene symbol STK39
Gene ID (NCBI) 27347
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

STK39 (Serine/Threonine Kinase 39) is a proline- and alanine-rich Ste20-related kinase (also named as SPAK), which is composed of a short N-terminal proline and alanine repeats (PAPA box), a kinase catalytic domain and a C-terminal regulatory domain (PMID: 16382158). In mammalians, STK39 plays an important role in ion homeostasis by regulating the cation chloride cotransporters' activities, which is crucial for the modulation of renal salt transport and blood pressure (PMID: 33500714). Notably, STK39 is also implicated in the regulation of tumor cell proliferation, migration, and invasion in multiple cancers, including osteosarcoma and cervical cancer (PMID: 34335956).